Pru p 3 acts as a strong sensitizer for peanut allergy in Spain

Slides:

Advertisements

Similar presentations

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

Advertisements

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.

Peanut-specific IgE antibodies in asymptomatic Ghanaian children possibly caused by carbohydrate determinant cross-reactivity Abena S. Amoah, MSc, Benedicta.

Detection of novel occupational wood allergens in locust wood dust (Robinia pseudoacacia L.) Sabine Kespohl, PhD, Rolf Merget, MD, Axel Overlack, MD,

Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.

Linear epitope mapping of peanut allergens demonstrates individualized and persistent antibody-binding patterns Christian S. Hansen, PhD, Martin Dufva,

The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.

Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies Marija Geroldinger-Simic, MD, Thomas Zelniker,

Allergen immunotherapy: A practice parameter third update

Clarification concerning amoxicillin skin testing

High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE Elizabeth A. Erwin,

Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life? Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.

Rosa Codina, PhD, Richard F. Lockey, MD

Linear epitope mapping of peanut allergens demonstrates individualized and persistent antibody-binding patterns Christian S. Hansen, PhD, Martin Dufva,

Is 9 more than 2 also in allergic airway inflammation?

Component-resolved diagnosis of wheat flour allergy in baker's asthma

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

T-cell involvement in delayed-type hypersensitivity reactions to infliximab Maria Jose Torres, MD, PhD, Patrícia Chaves, PhD, Inmaculada Doña, MD, Natalia.

Allergy testing in predicting outcome of open food challenge to peanut

Physician needs in health informatics: Just ask the docs

Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions Maria José Torres, MD, PhD,

Simultaneous detection of total and allergen-specific IgE by using purified allergens in a fluorescent multiplex array Eva-Maria King, PhD, Lisa D. Vailes,

Peter M. Wolfgram, MD, David B. Allen, MD

Etiology of asthma exacerbations

Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA

Protein unfolding strongly modulates the allergenicity and immunogenicity of Pru p 3, the major peach allergen Masako Toda, PhD, Gerald Reese, PhD, Gabriele.

Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S

Phillip Lieberman, MD, Michael Tankersley, MD

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen- specific immunotherapy Roberto González-Rioja, PhD, Ignacio Ibarrola,

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management Scott H. Sicherer, MD, Hugh A. Sampson, MD Journal.

Biosimilars and drug development in allergic and immunologic diseases

Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A

A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,

Serum ferritin and transferrin levels are not serologic markers of toluene diisocyanate– induced occupational asthma Joaquín Sastre, MD, PhD, Beatriz.

What is an “eosinophilic phenotype” of asthma?

Childhood allergic bronchopulmonary aspergillosis

Cockroach allergens: Coping with challenging complexity

Autophagy: Nobel Prize 2016 and allergy and asthma research

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Advances in the approach to the patient with food allergy

Local allergic rhinitis: Allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen Carmen Rondón, MD, PhD, Natalia.

Prevention of food allergy: Beyond peanut

Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies Marija Geroldinger-Simic, MD, Thomas Zelniker,

Peach allergy in China: A dominant role for mugwort pollen lipid transfer protein as a primary sensitizer Zhong-Shan Gao, PhD, Zhao-Wei Yang, BSc, Shan-Dong.

Diagnosis of Alternaria alternata sensitization with natural and recombinant Alt a 1 allergens Juan A. Asturias, PhD, Ignacio Ibarrola, PhD, Angel Ferrer,

Benjamin Chaigne, MD, Hervé Watier, MD, PhD

Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis Carmen Rondón, MD, PhD, Javier.

Pedro Gamboa, MD, PhD, Rosa Sanchez-Monge, PhD, M

Acid-suppressive drug use in pregnancy and the toddler's asthma risk: A crossover, case-control study Bianca Mulder, BSc, Catharina Carolina Maria Schuiling-Veninga,

Thunderstorm-related asthma attacks

Peanut oral immunotherapy decreases IgE to Ara h 2 and Ara h 6 but does not enhance sensitization to cross-reactive allergens Riikka Uotila, MD, Anna.

Päivi M. Salo, PhD, Samuel J. Arbes, DDS, MPH, PhD, Patrick W

Macrolide antibiotics and asthma treatment

Wheat lipid transfer protein is a major allergen associated with baker's asthma Arantxa Palacin, PhD, Santiago Quirce, MD, PhD, Alicia Armentia, MD, PhD,

Asthma: The past, future, environment, and costs

Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy– treated mother Sabine Flicker, PhD, Katharina Marth, MD, Heinz.

Environmental factors and eosinophilic esophagitis

Systemic responses after bronchial aspirin challenge in sensitive patients with asthma Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz,

The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.

Role of Art v 3 in pollinosis of patients allergic to Pru p 3

Natural history of cow’s milk allergy

Primary prevention of asthma and allergy

The Editors' Choice Journal of Allergy and Clinical Immunology

Immediate allergic reactions to cephalosporins: Evaluation of cross-reactivity with a panel of penicillins and cephalosporins Cristina Antunez, PhD,

Carl Hamsten, MSc, PhD, Thi Anh T

Presentation transcript:

Pru p 3 acts as a strong sensitizer for peanut allergy in Spain Gracia Javaloyes, MD, Maria J. Goikoetxea, MD, PhD, Ignacio García Nuñez, MD, Ana Aranda, PhD, Maria L. Sanz, MD, PhD, Miguel Blanca, MD, PhD, Araceli Diaz Perales, PhD, Juliana da Souza, BS, Irene Esparza, PhD, Victoria del Pozo, MD, PhD, Ana B. Blazquez, PhD, Stephan Scheurer, PhD, Stefan Vieths, PhD, Marta Ferrer, MD, PhD Journal of Allergy and Clinical Immunology Volume 130, Issue 6, Pages 1432-1434.e3 (December 2012) DOI: 10.1016/j.jaci.2012.08.038 Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Inhibition ELISA with Pru p 3, Ara h 9, and Cor a 8 immobilized in the solid phase and 4 concentrations (20, 10, 5, and 0.5 μg/mL) of these allergens as inhibitors in the fluid phase. Inhibition percentages of the IgE binding against the different solid phases when using the same allergens are represented as means and SDs of inhibition values. A, Inhibition percentage of the IgE binding of the patients (n = 20) with primary sensitization to Pru p 3. B, Inhibition percentage of the IgE binding of the patients (n = 6) with primary sensitization to Ara h 9. Journal of Allergy and Clinical Immunology 2012 130, 1432-1434.e3DOI: (10.1016/j.jaci.2012.08.038) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Inhibition ELISA with Pru p 3, Ara h 9, and Cor a 8 immobilized in the solid phase and 4 concentrations (20, 10, 5, and 0.5 μg/mL) of these allergens as inhibitors in the fluid phase. Percentages of inhibition of the IgE binding against the different solid phases when using the same allergens are represented. Journal of Allergy and Clinical Immunology 2012 130, 1432-1434.e3DOI: (10.1016/j.jaci.2012.08.038) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions